Scientific letter
Tocilizumab as a possible cause of ischemic colitis
Tocilizumab como posible causa de colitis isquémica
Rocío Forneiro Pérez
, Pablo Dabán López, María Sol Zurita Saavedra, María Dolores Hernández García, Benito Mirón Pozo
Corresponding author
Hospital Universitario Clínico San Cecilio, Granada, Spain
Read
382
Timeswas read the article
74
Total PDF
308
Total HTML
Share statistics
array:24 [ "pii" => "S2444382421001024" "issn" => "24443824" "doi" => "10.1016/j.gastre.2020.07.011" "estado" => "S300" "fechaPublicacion" => "2021-05-01" "aid" => "1654" "copyright" => "Elsevier España, S.L.U.. All rights reserved" "copyrightAnyo" => "2020" "documento" => "article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Gastroenterol Hepatol. 2021;44:373-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0210570520303599" "issn" => "02105705" "doi" => "10.1016/j.gastrohep.2020.07.016" "estado" => "S300" "fechaPublicacion" => "2021-05-01" "aid" => "1654" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Gastroenterol Hepatol. 2021;44:373-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICA</span>" "titulo" => "Tocilizumab como posible causa de colitis isquémica" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "373" "paginaFinal" => "374" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Tocilizumab as a possible cause of ischemic colitis" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 538 "Ancho" => 1250 "Tamanyo" => 152352 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Afectación por colitis isquémica: a la izquierda, afectación mucosa segmentaria con lesión ulcerada; a la derecha, colonoscopia a las dos semanas con úlcera de fondo fibrinado.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rocío Forneiro Pérez, Pablo Dabán López, María Sol Zurita Saavedra, María Dolores Hernández García, Benito Mirón Pozo" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Rocío" "apellidos" => "Forneiro Pérez" ] 1 => array:2 [ "nombre" => "Pablo" "apellidos" => "Dabán López" ] 2 => array:2 [ "nombre" => "María Sol" "apellidos" => "Zurita Saavedra" ] 3 => array:2 [ "nombre" => "María Dolores" "apellidos" => "Hernández García" ] 4 => array:2 [ "nombre" => "Benito" "apellidos" => "Mirón Pozo" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2444382421001024" "doi" => "10.1016/j.gastre.2020.07.011" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444382421001024?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210570520303599?idApp=UINPBA00004N" "url" => "/02105705/0000004400000005/v1_202104280833/S0210570520303599/v1_202104280833/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2444382421001127" "issn" => "24443824" "doi" => "10.1016/j.gastre.2020.07.013" "estado" => "S300" "fechaPublicacion" => "2021-05-01" "aid" => "1653" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Gastroenterol Hepatol. 2021;44:374-5" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>" "titulo" => "Massive upper gastrointestinal bleeding due to gastric lanthanosis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "374" "paginaFinal" => "375" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Hemorragia digestiva alta masiva secundaria a lantanosis gástrica" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1637 "Ancho" => 1677 "Tamanyo" => 431525 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(A) Gastroscopy image in retroversion, which shows abundant blood content as well as an erythematous lesion with a central whitish area (black arrow). (B) Hematoxylin-Eosin stain. We observed histiocyte aggregates and multinucleated giant cells, with deposition of a dark intracytoplasmic material and expansion of the lamina propia (black arrow).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Diego Martínez-Acitores de la Mata, Vanesa Jusué Irurita, Iranzu Ezcurra Acedo, Ángel Panizo Santos, Carlos Chaveli Díaz, Lucia Zabalza San Martín" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Diego Martínez-Acitores" "apellidos" => "de la Mata" ] 1 => array:2 [ "nombre" => "Vanesa Jusué" "apellidos" => "Irurita" ] 2 => array:2 [ "nombre" => "Iranzu Ezcurra" "apellidos" => "Acedo" ] 3 => array:2 [ "nombre" => "Ángel Panizo" "apellidos" => "Santos" ] 4 => array:2 [ "nombre" => "Carlos Chaveli" "apellidos" => "Díaz" ] 5 => array:2 [ "nombre" => "Lucia Zabalza" "apellidos" => "San Martín" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0210570520303587" "doi" => "10.1016/j.gastrohep.2020.07.015" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210570520303587?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444382421001127?idApp=UINPBA00004N" "url" => "/24443824/0000004400000005/v1_202105140801/S2444382421001127/v1_202105140801/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2444382421001140" "issn" => "24443824" "doi" => "10.1016/j.gastre.2020.08.007" "estado" => "S300" "fechaPublicacion" => "2021-05-01" "aid" => "1655" "copyright" => "Elsevier España, S.L.U." "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Gastroenterol Hepatol. 2021;44:369-73" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>" "titulo" => "Splenosis: An underappreciated cause of gastrointestinal bleeding in splenectomized patients. Case report and literature review" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "369" "paginaFinal" => "373" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Esplenosis: una causa subestimada de hemorragia gastrointestinal en el esplenectomizado. Caso clínico y revisión literaria" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Óscar Moralejo Lozano, Marta Aparicio Cabezudo, Marta Cruz Aparicio, Ana Caso Viesca, Michel Colmenares Bulgheroni, Adrián Joaquín Barrajón Masa, José Miguel Esteban López-Jamar" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Óscar" "apellidos" => "Moralejo Lozano" ] 1 => array:2 [ "nombre" => "Marta" "apellidos" => "Aparicio Cabezudo" ] 2 => array:2 [ "nombre" => "Marta" "apellidos" => "Cruz Aparicio" ] 3 => array:2 [ "nombre" => "Ana" "apellidos" => "Caso Viesca" ] 4 => array:2 [ "nombre" => "Michel" "apellidos" => "Colmenares Bulgheroni" ] 5 => array:2 [ "nombre" => "Adrián Joaquín" "apellidos" => "Barrajón Masa" ] 6 => array:2 [ "nombre" => "José Miguel" "apellidos" => "Esteban López-Jamar" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S0210570520303605" "doi" => "10.1016/j.gastrohep.2020.08.007" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0210570520303605?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444382421001140?idApp=UINPBA00004N" "url" => "/24443824/0000004400000005/v1_202105140801/S2444382421001140/v1_202105140801/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>" "titulo" => "Tocilizumab as a possible cause of ischemic colitis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "373" "paginaFinal" => "374" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Rocío Forneiro Pérez, Pablo Dabán López, María Sol Zurita Saavedra, María Dolores Hernández García, Benito Mirón Pozo" "autores" => array:5 [ 0 => array:4 [ "nombre" => "Rocío" "apellidos" => "Forneiro Pérez" "email" => array:1 [ 0 => "rocio.forneiro@gmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Pablo" "apellidos" => "Dabán López" ] 2 => array:2 [ "nombre" => "María Sol" "apellidos" => "Zurita Saavedra" ] 3 => array:2 [ "nombre" => "María Dolores" "apellidos" => "Hernández García" ] 4 => array:2 [ "nombre" => "Benito" "apellidos" => "Mirón Pozo" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Hospital Universitario Clínico San Cecilio, Granada, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Tocilizumab como posible causa de colitis isquémica" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 538 "Ancho" => 1250 "Tamanyo" => 152560 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Impairment due to ischaemic colitis: on the left, segmental mucosal impairment with an ulcerated lesion; on the right, colonoscopy after two weeks showing an ulcer with a fibrinated base.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">In December 2019, a novel coronavirus, called SARS-CoV-2, was isolated as a causative agent of a new form of pneumonia that has spread globally since then and was subsequently renamed COVID-19 by the World Health Organization.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> According to data from the Spanish Ministry of Health, as of 1 May 2020, the number of cases diagnosed by PCR in Spain surpassed 215,000 and the number of deaths stood at around 25,000, representing a mortality rate of 11.6%.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Some patients experience cytokine release syndrome. Interleukin-6 (IL-6) is the key molecule in this cytokine storm.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Tocilizumab, a humanised recombinant monoclonal antibody, acts against the IL-6 receptor. For that reason, it has come to be used in patients with serious COVID-19 and elevated IL-6. Despite the apparent benefits reported, the possible adverse effects of this agent should be borne in mind. We report the case of a patient treated with tocilizumab for serious COVID-19 who presented signs and symptoms consistent with segmental ischaemic colitis.</p><p id="par0015" class="elsevierStylePara elsevierViewall">A 59-year-old man was admitted to the intensive care unit for bilateral pneumonia due to SARS-CoV-2, complicated by moderate to severe acute respiratory distress syndrome (ARDS) requiring prolonged orotracheal intubation. Notable elements of his medical history were hypertension and ischaemic cardiomyopathy, for which he underwent revascularisation in February 2020 and was on dual antiplatelet therapy. After three days with boluses of methylprednisolone, the patient's condition worsened, with unfavourable laboratory and radiological test results, for which a single dose of 600<span class="elsevierStyleHsp" style=""></span>mg of intravenous tocilizumab was prescribed. Ten days following administration of this drug, the patient started to have episodes of haematochezia which required transfusion of four units of packed red blood cells and one unit of platelets (two units of packed red blood cells approximately every 48−72<span class="elsevierStyleHsp" style=""></span>h) due to the onset of multifactorial anaemia, as he reached haemoglobin levels of 7.2<span class="elsevierStyleHsp" style=""></span>g/dl.</p><p id="par0020" class="elsevierStylePara elsevierViewall">He underwent a colonoscopy 24<span class="elsevierStyleHsp" style=""></span>h after the first episode of haematochezia. The procedure revealed digested blood debris (with no active bleeding) up to the hepatic flexure and signs in the mucosa of ischaemic colitis with two ulcers and an adhered clot 55–65<span class="elsevierStyleHsp" style=""></span>cm from the external anal margin (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). This colonoscopy was complete, although ileoscopy was not performed. A gastroscopy showed several gastric ulcers measuring around a millimetre suggestive of acute gastric mucosa lesions with no blood debris and no signs of active bleeding. In view of the endoscopic findings and the patient’s context, he was put on digestive rest with parenteral nutrition and broad-spectrum empirical antibiotic therapy. Days later, given the persistence of the patient’s haematochezia, a computed tomography (CT) angiography of the abdomen was ordered. This ruled out active bleeding and artery occlusion. It also found no segmental thickening or signs of a poor prognosis in the colon wall. As of that day, the patient's antiplatelet therapy was suspended. Two weeks from the first episode, the bleeding from the patient's rectum had been self-limited, so a decision was made to perform another colonoscopy (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). This test showed the same lesions, now fibrinated, and improvement of the mucosal impairment in the same colon segment that was reported in the first endoscopy and classified as segmental ischaemic colitis. The colonoscopies found no diverticula in the colon.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">The most common form of intestinal ischaemia is ischaemic colitis. It typically presents with colicky pain, defecation urgency and rectal bleeding. Most patients have mild forms that resolve within a few days with the mucosa recovering in two to three weeks. However, in more serious cases, recovery from the lesions may take up to six months, even if the patient remains asymptomatic. In addition, it must not be forgotten that a possible complication is bowel perforation.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">The recent COVID-19 outbreak has been deemed a global health emergency. As of the time of writing, there is still no effective treatment or available vaccine. Tocilizumab is useful in selected cases.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Some possible adverse effects of a gastrointestinal nature of this drug are gastric ulcers (<2%), diverticulitis and gastrointestinal perforation.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> In our case, the patient presented colonic ulcers with episodes of haematochezia resulting in anaemia, which lasted for two weeks and ultimately were self-limiting.</p><p id="par0035" class="elsevierStylePara elsevierViewall">The Naranjo algorithm was applied to determine the probability of a causal relationship between tocilizumab administration and ischaemic colitis, with a result of four points. Given all this, the possibility of an association must be taken into account. There are other limitations, such as the absence of a histological diagnosis of said ulcers, the presence of prior vascular disease and the patient's exposure to other events promoting possible ischaemic colitis (sepsis, hypotension, systemic impairment that required intensive care, etc.).</p><p id="par0040" class="elsevierStylePara elsevierViewall">At present, in Spain there are several studies for evaluating the effects of tocilizumab in critically ill patients. Future lines of research could lead to studying the possible relationship between tocilizumab and ischaemic colitis. Few studies have observed an increase in gastrointestinal perforation in patients with rheumatoid arthritis who receive tocilizumab, although the mechanism by which such damage occurs is unknown. One hypothesis points to inhibition by IL-6 of vascular endothelial growth factor, which plays an important role in maintaining the integrity of the intestinal mucosa when it is damaged.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Funding</span><p id="par0045" class="elsevierStylePara elsevierViewall">There were no sources of funding for this work.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Conflicts of interest</span><p id="par0050" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Funding" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Conflicts of interest" ] 2 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Forneiro Pérez R, Dabán López P, Zurita Saavedra MS, Hernández García MD, Mirón Pozo B. Tocilizumab como posible causa de colitis isquémica. Gastroenterol Hepatol. 2021;44:373–374.</p>" ] ] "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 538 "Ancho" => 1250 "Tamanyo" => 152560 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Impairment due to ischaemic colitis: on the left, segmental mucosal impairment with an ulcerated lesion; on the right, colonoscopy after two weeks showing an ulcer with a fibrinated base.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:5 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical management of severe acute respiratory infection when COVID-19 is suspected (v1.2)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "World Healthy Organization" ] ] ] ] ] "host" => array:2 [ 0 => array:1 [ "Libro" => array:4 [ "fecha" => "2020" "paginaInicial" => "1" "paginaFinal" => "21" "editorial" => "WHO" ] ] 1 => array:1 [ "WWW" => array:1 [ "link" => "https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Consumo y Bienestar Social" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Instituto de Salud Carlos lll. Situación de COVID-19 o Coronavirus en España. Ministerio de Sanidad" ] ] ] ] ] "host" => array:2 [ 0 => array:1 [ "Libro" => array:1 [ "fecha" => "2020" ] ] 1 => array:1 [ "WWW" => array:1 [ "link" => "https://covid19.isciii.es/" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "C. Zhang" 1 => "Z. Wu" 2 => "J.W. Li" 3 => "H. Zhao" 4 => "G.Q. Wang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ijantimicag.2020.105954" "Revista" => array:2 [ "tituloSerie" => "Int J Antimicrob Agents" "fecha" => "2020" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "ACG clinical guideline: Epidemiology, risk factors, patterns of presentation, diagnosis, and management of colon ischemia (CI)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "L.J. Brandt" 1 => "P. Feuerstadt" 2 => "G.F. Longstreth" 3 => "S.J. Boley" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/ajg.2014.395" "Revista" => array:6 [ "tituloSerie" => "Am J Gastroenterol" "fecha" => "2015" "volumen" => "110" "paginaInicial" => "18" "paginaFinal" => "44" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25559486" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Tocilizumab: Drug information - UpToDate. https://www.uptodate.com/contents/tocilizumab-drug-information?search=tocilizumab covid⊤icRef=127429&source=see_link#F9773765. Accessed April 30, 2020." ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/24443824/0000004400000005/v1_202105140801/S2444382421001024/v1_202105140801/en/main.assets" "Apartado" => array:4 [ "identificador" => "77930" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Scientific letter" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/24443824/0000004400000005/v1_202105140801/S2444382421001024/v1_202105140801/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2444382421001024?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 1 | 0 | 1 |
| 2024 October | 15 | 2 | 17 |
| 2024 September | 47 | 13 | 60 |
| 2024 August | 35 | 10 | 45 |
| 2024 July | 22 | 4 | 26 |
| 2024 June | 21 | 4 | 25 |
| 2024 May | 9 | 3 | 12 |
| 2024 April | 17 | 3 | 20 |
| 2024 March | 21 | 4 | 25 |
| 2024 February | 22 | 2 | 24 |
| 2024 January | 22 | 3 | 25 |
| 2023 December | 16 | 2 | 18 |
| 2023 November | 16 | 6 | 22 |
| 2023 October | 6 | 5 | 11 |
| 2023 September | 13 | 1 | 14 |
| 2023 August | 7 | 1 | 8 |
| 2023 July | 5 | 2 | 7 |
| 2023 June | 7 | 6 | 13 |
| 2023 May | 5 | 1 | 6 |
| 2023 March | 1 | 0 | 1 |
| 2021 May | 0 | 2 | 2 |
Show all
